Literature DB >> 27071803

The association between ABO blood group and obstetric hemorrhage.

Lior Drukker1, Naama Srebnik2, Deborah Elstein1, Lorinne Levitt3, Arnon Samueloff1, Rivka Farkash1, Sorina Grisaru-Granovsky1, Hen Y Sela1.   

Abstract

UNLABELLED: Whether intra- and early post-partum hemorrhage is influenced by ABO blood groups remains unknown. Therefore, we compared women with O to non-O blood groups with regard to maternal post-partum hemorrhage and transfusion need. This retrospective study was conducted in a single tertiary center between 2005 and 2014. For the purpose of the study, parturients were categorized as O and non-O blood groups. Data included all deliveries but excluded patients with missing blood grouping or hemoglobin values, and/or stillbirth. Drop in hemoglobin was defined as hemoglobin concentration at admission for delivery minus lowest hemoglobin concentration post-delivery. Study outcomes were postpartum hemorrhage, hemoglobin drop >2-7 g/dL inclusive, and packed red blood cells transfusion. STATISTICS: descriptive, χ(2) (p < 0.05 significant) and multivariable regression models [odds ratio (OR), 95 % confidence interval (CI), p value]. 125,768 deliveries were included. After multivariable analysis, women with O blood type relative to women with non-O blood type had significantly higher odds of postpartum hemorrhage (OR 1.14; 95 % CI 1.05-1.23, p < 0.001), higher odds of statistically significant hemoglobin decreases of >2, 3, or 4 g/dL (OR 1.07; 95 % CI 1.04-1.11, p < 0.001, OR 1.08; 95 % CI 1.03-1.14, p = 0.002, OR 1.14; 95 % CI 1.05-1.23, p = 0.001; respectively), and higher odds, albeit not statistically significant of 5, 6, or 7 g/dL decreases in hemoglobin (OR 1.13; 95 % CI 1.00-1.29, p = 0.055, OR 1.05; 95 % CI 0.84-1.32, p = 0.66, OR 1.15; 95 % CI 0.79-1.68, p = 0.46; respectively), but no difference in blood products transfusion (OR 1.03; 95 % CI 0.92-1.16, p = 0.58). In conclusion, women with blood type O may be at greater risk of obstetrical hemorrhage.

Entities:  

Keywords:  Anemia; Blood group; Blood transfusion; Delivery; Maternal outcome; Postpartum hemorrhage

Mesh:

Substances:

Year:  2016        PMID: 27071803     DOI: 10.1007/s11239-016-1360-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  17 in total

1.  Trends in postpartum hemorrhage: United States, 1994-2006.

Authors:  William M Callaghan; Elena V Kuklina; Cynthia J Berg
Journal:  Am J Obstet Gynecol       Date:  2010-04       Impact factor: 8.661

2.  Visually estimated and calculated blood loss in vaginal and cesarean delivery.

Authors:  Irene Stafford; Gary A Dildy; Steven L Clark; Michael A Belfort
Journal:  Am J Obstet Gynecol       Date:  2008-07-17       Impact factor: 8.661

3.  Blood component therapy in postpartum hemorrhage.

Authors:  Andra H James; Michael J Paglia; Terry Gernsheimer; Chad Grotegut; Betty Thames
Journal:  Transfusion       Date:  2009-07-16       Impact factor: 3.157

4.  ABO blood groups in gastric bleeding.

Authors:  L Horwich; D A Evans; R B McConnell; W T Donohoe
Journal:  Gut       Date:  1966-12       Impact factor: 23.059

5.  Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.

Authors:  J P Kuyvenhoven; R A Veenendaal; J P Vandenbroucke
Journal:  Scand J Gastroenterol       Date:  1999-11       Impact factor: 2.423

6.  Maternal obesity, mode of delivery, and neonatal outcome.

Authors:  Marie Blomberg
Journal:  Obstet Gynecol       Date:  2013-07       Impact factor: 7.661

7.  The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes.

Authors:  Peter Clark; Isobel D Walker; Lindsay Govan; Olivia Wu; Ian A Greer
Journal:  Br J Haematol       Date:  2007-11-19       Impact factor: 6.998

8.  How accurate is the reporting of obstetric haemorrhage in hospital discharge data? A validation study.

Authors:  Samantha J Lain; Christine L Roberts; Ruth M Hadfield; Jane C Bell; Jonathan M Morris
Journal:  Aust N Z J Obstet Gynaecol       Date:  2008-10       Impact factor: 2.100

9.  Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes.

Authors:  Lior Drukker; Yael Hants; Rivka Farkash; Rosa Ruchlemer; Arnon Samueloff; Sorina Grisaru-Granovsky
Journal:  Transfusion       Date:  2015-08-04       Impact factor: 3.157

10.  Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy.

Authors:  K Wickström; G Edelstam; C H Löwbeer; L O Hansson; A Siegbahn
Journal:  Scand J Clin Lab Invest       Date:  2004       Impact factor: 1.713

View more
  4 in total

1.  Blood type association with bleeding outcomes at delivery in a large multi-center study.

Authors:  Najeebah A Bade; Jamil M Kazma; Richard L Amdur; Julia Ellis-Kahana; Homa K Ahmadzia
Journal:  J Thromb Thrombolysis       Date:  2020-08       Impact factor: 2.300

2.  Evaluation of blood type as a potential risk factor for early postpartum hemorrhage.

Authors:  Mais Ali-Saleh; Ofer Lavie; Yoram Abramov
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

3.  Clinical characteristics and hematological parameters associated with disease severity in COVID-19 positive pregnant women undergoing cesarean section: A single-center experience.

Authors:  Baris Arslan; Ilhan G Bicer; Tuna Sahin; Merve Vay; Okan Dilek; Emre Destegul
Journal:  J Obstet Gynaecol Res       Date:  2021-11-27       Impact factor: 1.730

4.  Establishment of the Normal Reference Range of Thrombelastogram among the Healthy Population and Pregnants in China.

Authors:  Rong Gui; Xueyuan Huang; Ming Zhou; Shujuan Ouyang; Yunfeng Fu; Hao Tang; Fengxia Liu; Rong Huang; Meng Gao; Hang Dong; Yongjun Wang
Journal:  Iran J Public Health       Date:  2019-05       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.